Browse

browse by

32records

AATBC

alias symbols:

tissues bladder

cancer type bladder cancer

LncRNA AATBC is over-expressed in bladder cancer, associated with tumor development and aggressiveness. AATBC depletion leads to an obvious inhibitory effect on the cellular growth of bladder cancer, and inhibits tumor growth in NOD/SCID mice. Knockdown of AATBC leads to an increased expression of p18 but a decreased expression of cyclin D1, CDK4, and phosphorylated retinoblastoma (Rb). It can also result in the intrinsic apoptosis of bladder cancer cells by the enhanced cleavages of poly (ADP-ribose) polymerase (PARP), caspase-9 and caspase-3. It can also enhance the phosphorylation level ...


ANRIL

alias symbols:

tissues bladder,breast,cervix,colorectum,esophagus,gallbladder,liver,lung,nasopharynx,others,ovary,prostate,stomach,thyroid

cancer type bladder cancer,breast cancer,cervical cancer,colorectal cancer,epithelial ovarian cancer,esophageal squamous cell cancer,gallbladder cancer,gastric cancer,hepatic cancer,lung cancer,melanoma,nasopharyngeal cancer,non-small-cell lung cancer,ovarian cancer,prostate cancer,thyroid cancer

ANRIL is an oncogene in multiple cancers. It is significantly up-regulated in nasopharyngeal carcinoma (NPC), thyroid cancer, non-small cell lung cancer (NSCLC), esophageal squamous cell carcinoma, gastric cancer, hepatocellular carcinoma, gallbladder cancer, colorectal cancer, breast cancer, serous ovarian cancer (SOC), bladder cancer, and prostate cancer. Overexpression of ANRIL is associated with clinicopathological parameters such as tumor size, TNM stage etc. and can be identified as a prognostic predictor. Functionally, ANRIL can promote the proliferation, migration and invasion of ca...


CCAT1

alias symbols:

tissues bone marrow,breast,colorectum,endometrium,gallbladder,liver,lung,stomach

cancer type acute myelocytic leukemia,breast cancer,colorectal cancer,endometrial cancer,gallbladder cancer,gastric adenocarcinoma,gastric cancer,hepatic cancer,non-small-cell lung cancer

LncRNA CCAT1 is higher in breast cancer, colorectal cancer, gallbladder cancer, gastric cancer and hepatocellular carcinoma. CCAT1 expression level is associated with clinicopathological parameters such as differentiation grade, TNM stage, lymph node metastases, prognosis etc.. Functionally, CCAT1 regulates cancer cell proliferation, migration, metastasis, invasion and apoptosis. Further studies reveal that CCAT1 can bind to miRNA-218-5p, c-Myc and let-7. Moreover, CCAT1 can negatively regulate Bmi1, miR-490 and positively regulate c-Myc, HMGA2 and hnRNAP1.


GAS5

alias symbols:

tissues bladder,bone marrow,breast,cervix,colorectum,endometrium,kidney,liver,lung,nervous system,others,ovary,pancreas,pleura,prostate,stomach

cancer type bladder cancer,breast cancer,cervical cancer,colorectal cancer,endometrial cancer,gastric cancer,glioma,hepatic cancer,lung adenocarcinoma,malignant pleural mesothelioma,mantle cell lymphoma cell,melanoma,non-small-cell lung cancer,ovarian cancer,pancreatic cancer,prostate cancer,renal cancer

LncRNA GAS5 is a tumor suppressor gene. GAS5 level is significantly down-regulated in glioma, melanoma, mantle cell lymphoma cell, lung cancer, malignant pleural mesothelioma, breast cancer, gastric cancer, liver cancer, pancreatic cancer, colorectal cancer, cervical cancer, endometrial cancer, bladder cancer, prostate cancer and renal cell carcinoma. Low GAS5 level is associated with tumor size, lymph node metastasis, TNM stage, deeper depth of invasion and poor prognosis. Functionally, GAS5 can inhibit proliferation, migration, invasion and apoptosis of various cancer cells. It can direct...


GHET1

alias symbols:

tissues bladder,colorectum,stomach

cancer type bladder cancer,colorectal cancer,gastric cancer

LncRNA GHET1 is up-regulated in bladder cancer, colorectal cancer and gastric cancer. Increased GHET1 expression is correlated with advanced tumor status, grade and poor prognosis of bladder cancer and gastric cancer. Functionally, GHET1 promotes cell proliferation and invasion. Mechanistically, GHET1 negatively regulates p16 and p21, thus promoting cell proliferation. Moreover, GHET1 increases expression of vimentin, Snail, Slug, Twist, ZEB1 and fibronectin (mesenchymal marker) and decreases E-cadherin protein level (epithelial marker). As a consequence, EMT is promoted, and cancer cell in...


H19

alias symbols:

tissues bladder,bone,bone marrow,breast,colorectum,esophagus,gallbladder,kidney,larynx,liver,lung,nasopharynx,nervous system,others,ovary,pancreas,prostate,stomach,thyroid

cancer type bladder cancer,breast cancer,colorectal cancer,embryonic carcinoma,esophageal cancer,gallbladder cancer,gastric cancer,glioma,hepatic cancer,laryngeal squamous cell cancer,leukemia,lung cancer,nasopharyngeal cancer,non-small-cell lung cancer,osteosarcoma,ovarian cancer,pancreatic cancer,prostate cancer,renal cancer,thyroid cancer

LncRNA H19 is a precursor of miR-675-5p/miR-675-3p. It mainly acts as an oncogene in multiple cancers. It is higher in glioma, thyroid cancer, nasopharyngeal carcinoma, non-small-cell lung cancer, breast cancer, esophageal cancer, gastric cancer, gallbladder carcinoma, pancreatic cancer, colon cancer, bladder cancer, renal cell carcinoma, ovarian cancer, embryonic carcinoma, but has dual roles in hepatocellular carcinoma. H19 expression level is associated with clinicopathological parameters such as tumor differentiation, TNM stage and prognosis etc.. Functionally, H19 regulates cancer cell...


HIF1A-AS2

alias symbols:

tissues bladder,stomach

cancer type bladder cancer,gastric cancer

LncRNA HIF1A-AS2 is up-regulated in gastric cancer (GC) and bladder cancer. Overexpression of HIF1A-AS2 is significantly associated with tumor invasion, lymph node metastasis, higher TNM stage and shorter overall survival (OS) time. Besides, HIF1A-AS2 can promote the proliferation of GC cells and promote cell proliferation, migration and inhibit cell apoptosis in bladder cancer.


HOTAIR

alias symbols:

tissues bladder,bone,bone marrow,breast,cervix,colorectum,endometrium,esophagus,gallbladder,kidney,larynx,liver,lung,nasopharynx,nervous system,others,ovary,pancreas,prostate,stomach,thyroid

cancer type acute myelocytic leukemia,bladder cancer,breast cancer,cervical cancer,colorectal cancer,diffuse large B cell lymphoma,endometrial cancer,epithelial ovarian cancer,esophageal squamous cell cancer,gallbladder cancer,gastric adenocarcinoma,gastric cancer,gastrointestinal stromal tumors,glioma,head and neck squamous cell cancer,hepatic cancer,laryngeal squamous cell cancer,lung adenocarcinoma,lung cancer,melanoma,nasopharyngeal cancer,non-small-cell lung cancer,oral squamous cell cancer,osteosarcoma,ovarian cancer,pancreatic cancer,papillary thyroid cancer,phenotype of urothelial cancer,prostate cancer,renal cancer,sarcoma,small cell lung cancer,triple negative breast cancer

HOTAIR is a relatively well studied oncogene. It is higher in acute myelocytic leukemia (AML), glioma, laryngeal squamous cell carcinoma, oral squamous carcinoma, nasopharyngeal carcinoma, lung cancer, esophageal squamous cell carcinoma, gastric cancer, hepatocellular carcinoma, gallbladder cancer, pancreatic cancer, colorectal cancer, melanoma, osteosarcoma, bladder cancer, renal carcinoma, ovarian cancer, cervical cancer and endometrial carcinoma. Its expression level is associated with clinicopathological parameters such as lymph node metastasis, tumor size, prognosis. Functionally, HOTA...


HOXD-AS1

alias symbols:

tissues bladder,nervous system

cancer type bladder cancer,neuroblastoma

LncRNA HOXD-AS1 is up-regulated in bladder cancer and neuroblastoma. HOXD-AS1 is positively correlated with tumor size, histological grade and TNM stage in bladder cancer. HOXD-AS1 can promote bladder cancer cell proliferation, migration and inhibit apoptosis. HOXD-AS1 is up-regulated by retinoic acid in SH-SY5Y neuroblastoma cell line. Besides, HOXD-AS1 expression is regulated by PI3K/Akt signaling pathway.


KIAA0125

alias symbols:

tissues gallbladder

cancer type gallbladder cancer

LncRNA KIAA0125 is remarkably up-regulated in gallbladder (GBC). KIAA0125 can promote cell migration and invasion. Moreover, KIAA0125 can influence EMT by affecting expression of β-Catenin and Vimentin.


LET

alias symbols:

tissues cervix,esophagus,gallbladder,liver,nasopharynx,stomach

cancer type cervical cancer,esophageal squamous cell cancer,gallbladder cancer,gastric cancer,hepatic cancer,nasopharyngeal cancer

LncRNA LET is lower in nasopharyngeal carcinoma, esophageal squamous cell carcinoma, gallbladder cancer, gastric cancer, hepatic carcinoma,colorectal cancer,lung squamous cell cancer, and cervical cancer. LET expression level is associated with clinicopathological parameters such as pathological grade, clinical stage, lymph node metastasis, prognosis etc.. LET regulates cancer cell proliferation, migration, metastasis, invasion and apoptosis. LET play biological functions via negatively regulating Bcl-2 and positively regulates p53, p21, caspase-3, Bax. Moreover, LET can regulate hypoxia si...


LOC572558

alias symbols:

tissues bladder

cancer type bladder cancer

LOC572558 expression is markedly decreased in bladder cancer tissues and bladder cancer cell lines. Moreover, ectopic expression of LOC572558 inhibits cell proliferation and motility, induces S phase arrest of the cell cycle and promotes cell apoptosis in bladder cancer cell lines. Further studies verify that overexpression of LOC572558 is associated with dephosphorylation of AKT, MDM2 and phosphorylation of p53 protein.


Linc-ITGB1

alias symbols:

tissues breast,gallbladder

cancer type breast cancer,gallbladder cancer

LncRNA linc-ITGB1 is higher in breast cancer and gallbladder cancer. It regulates cancer cell proliferation, migration and invasion via regulating Cdc25C, Cyclin B1, E-cadherin, N-cadherin, vimentin and Snail.


MALAT1

alias symbols: mascRNA, LINC00047, NCRNA00047,PRO1073, HCN, NEAT2, MALAT-1

tissues bladder,bone,bone marrow,breast,cervix,colorectum,endometrium,esophagus,gallbladder,kidney,liver,lung,nasopharynx,nervous system,others,ovary,pancreas,prostate,stomach

cancer type bladder cancer,breast cancer,cervical cancer,colorectal cancer,endometrial cancer,esophageal cancer,esophageal squamous cell cancer,gallbladder cancer,gastric cancer,glioma,hepatic cancer,lung adenocarcinoma,lung cancer,middle thoracic esophageal cancer,multiple myeloma,nasopharyngeal cancer,neuroblastoma,non-small cell lung cancer,non-small-cell lung cancer,oral squamous cell cancer,osteosarcoma,ovarian cancer,pancreatic cancer,prostate cancer,renal cancer,renal clear cell cancer,tongue cancer,triple negative breast cancer

MALAT1 is a well-studied long non-coding RNA. It acts as an oncogene in multiple cancers. It is higher in glioma,tongue cancer, oral squamous cell carcinoma, esophageal cancer, lung cancer, breast cancer, gastric cancer, hepatic carcinoma, multiple myeloma, gallbladder cancer, osteosarcoma, pancreatic cancer, colorectal cancer, prostate cancer, bladder cancer, renal cell carcinoma, cervical cancer and ovarian cancer. MALAT1 expression level is associated with clinicopathological parameters such as tumor size, TNM stage, vascular invasion, lymph node metastasis, prognosis. Functionally, MALA...


MDC1-AS

alias symbols:

tissues bladder,nervous system

cancer type bladder cancer,glioma

LncRNA MDC1-AS is up-regulated in bladder cancer and glioma and positively associated with MDC1. It has a role on cell proliferation.


MEG3

alias symbols:

tissues bladder,bone,bone marrow,breast,cervix,colorectum,endometrium,gallbladder,kidney,liver,lung,nervous system,others,ovary,pancreas,prostate,stomach,thyroid

cancer type acute myelocytic leukemia,bladder cancer,breast cancer,cervical cancer,colorectal cancer,endometrial cancer,gallbladder cancer,gastric cancer,glioma,hepatic cancer,lung adenocarcinoma,lung cancer,myelodysplastic syndrome,non-small-cell lung cancer,osteosarcoma,ovarian cancer,pancreatic cancer,prostate cancer,renal cancer,thyroid cancer,tongue squamous cell cancer

MEG3 is a well-studied tumor suppressor gene. It is lower in thyroid carcinoma, lung cancer, gastric cancer, hepatic carcinoma, osteosarcoma, pancreatic cancer, colorectal cancer, renal cell carcinoma, prostate cancer, cervical carcinoma and endometrial carcinoma. MEG3 expression level is associated with clinicopathological parameters such as tumor size, TNM stage, lymph node metastasis, prognosis. Cell functional studies reveal that MEG3 regulates cancer cell proliferation, migration, metastasis, invasion and apoptosis. At molecular level, MEG3 can bind to miR-181 and Rac1. Moreover, MEG3 ...


MINCR

alias symbols:

tissues bone marrow,gallbladder

cancer type Burkitt lymphoma,gallbladder cancer

LncRNA MINCR has the highest and most significant positively correlated with MYC expression level. It has the MYC binding regions around its transcriptional start site (TSS) in burkitt lymphoma (BL) cells and P493-6 cells, with increasing peak intensity in MYC high conditions in P493-6 cells. Moreover, MINCR has all of the marks associated with open chromatin and active transcription in normal and malignant B cells. Besides, the expression of MINCR is reduced after MYC knockdown in BL cell lines. Functionally, MINCR knockdown is associated with impairment in cell cycle progression. Differen...


MIR31HG

alias symbols:

tissues bladder,breast,colorectum,stomach

cancer type bladder cancer,breast cancer,colorectal cancer,gastric cancer,triple negative breast cancer

LncRNA MIR31HG is higher in breast cancer, lower in colorectal cancer, triple negative reast Cancer, bladder cancer, and gastric cancer. It can regulate cancer cell proliferation, migration, invasion and apoptosis. Mechanistically, it can regulate E2F1 and p21.


NEAT1

alias symbols:

tissues bladder,bone marrow,colorectum,esophagus,larynx,liver,lung,nasopharynx,nervous system,ovary,prostate,stomach

cancer type acute promyelocytic leukemia,bladder cancer,colorectal cancer,esophageal squamous cell cancer,gastric cancer,glioma,hepatic cancer,laryngeal squamous cell cancer,leukemia,lung cancer,nasopharyngeal cancer,non-small-cell lung cancer,ovarian cancer,prostate cancer

LncRNA NEAT1 is an oncogene and it is higher in glioma, laryngeal squamous cell cancer, esophageal squamous cell carcinoma, lung cancer, gastric cancer, hepatic carcinoma, colorectal cancer, bladder cancer and ovarian cancer. NEAT1 expression level is associated with clinicopathological parameters such as differentiation, lymph node metastasis, TNM stage prognosis. NEAT1 regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. Mechanistically, NEAT1 can bind to miR-449b-5p, hsa-miR-377-3p, miR‐124‐3p and HuR. Furthermore, NEAT1 negatively regulates CDK6, Zo-1...


PANDAR

alias symbols:

tissues bladder,breast,liver,lung,stomach

cancer type bladder cancer,breast cancer,gastric cancer,hepatic cancer,non-small-cell lung cancer

LncRNA PANDAR is higher in breast cancer, gastric cancer, hepatocellular carcinoma and bladder cancer, and lower in lung cancer. PANDAR expression level is associated with clinicopathological parameters such as depth of invasion lymphatic metastasis, histological grade, TNM stage and prognosis etc.. Functionally, PANDAR regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. Mechanistically, PANDAR negatively regulates p16 and Bcl-2.


PCAT1

alias symbols:

tissues bladder,colorectum,esophagus,liver,lung,prostate

cancer type bladder cancer,colorectal cancer,esophageal squamous cell cancer,hepatic cancer,non-small-cell lung cancer,prostate cancer

LncRNA PCAT1 is higher in bladder cancer, esophageal squamous carcinoma colorectal cancer, hepatocellular carcinoma, lung cancer and prostate cancer. PCAT1 expression level is associated with clinicopathological parameters such as TNM stage, depth of tumor invasion, lymph node metastasis, prognosis etc.. Moreover, PCAT1 regulates cancer cell proliferation, migration, metastasis, invasion and apoptosis. Besides, PCAT1 negatively regulates caspase-3.


PVT1

alias symbols:

tissues bladder,bone marrow,breast,cervix,colorectum,kidney,liver,lung,ovary,pancreas,pleura,stomach,thyroid

cancer type acute promyelocytic leukemia,bladder cancer,breast cancer,cervical cancer,colorectal cancer,gastric cancer,hepatic cancer,malignant pleural mesothelioma,non-small-cell lung cancer,ovarian cancer,pancreatic cancer,renal cancer,thyroid cancer

LncRNA PVT1 is higher in acute promyelocytic leukemia (APL), malignant pleural mesothelioma, non-small cell lung cancer (NSCLC), breast cancer, ovarian cancer, cervical cancer(27232880), gastric cancer, pancreatic cancer, colorectal cancer, bladder cancer and renal carcinoma. PVT1 expression level is associated with clinicopathological parameters such as lymph node metastasis, TNM stage, prognosis etc.. Functionally, PVT1 regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. At molecular level, PVT1 can bind to EZH2. Moreover, PVT1 negatively regulates miR...


SChLAP1

alias symbols:

tissues bladder,prostate

cancer type bladder cancer,prostate cancer

LncRNA SChLAP1 is higher in bladder cancer and prostate cancer. SChLAP1 regulates cancer cell proliferation, migration, metastasis, invasion and apoptosis. Mechanistically, SChLAP1 can bind to SWI/SNF chromatin-modifying complex and negatively regulates SNF5.


SPRY4-IT1

alias symbols:

tissues bladder,breast,colorectum,esophagus,kidney,liver,lung,nervous system,others,stomach

cancer type bladder cancer,breast cancer,colorectal cancer,esophageal squamous cell cancer,gastric cancer,glioma,hepatic cancer,melanoma,non-small-cell lung cancer,renal clear cell cancer

LncRNA SPRY4-IT1 is higher in esophageal squamous cell carcinoma, glioma, melanoma, colorectal cancer, bladder cancer(25973088), clear cell renal cell carcinoma, lower in non-small cell lung cancer (NSCLC), but has dual roles in gastric cancer. SPRY4-IT1 expression level is associated with clinicopathological parameters such as tumor stage, histological grade, lymph node metastasis, prognosis etc.. Functionally, SPRY4-IT1 regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. Mechanistically, SPRY4-IT1 negatively regulates E-cadherin, ZO-1 and positively re...


SUMO1P3

alias symbols:

tissues bladder,stomach

cancer type bladder cancer,gastric cancer

LncRNA SUMO1P3 is significantly up-regulated in bladder cancer tissues and gastric cancer. Moreover, up-regulated SUMO1P3 expression is correlated with clinicopathological parameters. Furthermore, SUMO1P3 can promote cell proliferation, migration and inhibit apoptosis of bladder cancer cells.


TUG1

alias symbols:

tissues bladder,bone,colorectum,esophagus,kidney,liver,lung,nervous system,stomach

cancer type bladder cancer,colorectal cancer,esophageal squamous cell cancer,gastric cancer,glioma,hepatic cancer,hepatoblastoma,non-small-cell lung cancer,osteosarcoma,renal cancer

LncRNA TUG1 is higher in esophageal squamous cell carcinoma, gastric cancer, hepatocellular carcinoma, osteosarcoma, colorectal cancer and bladder cancer, and lower in glioma andnon-small cell lung cancer (NSCLC). TUG1 expression level is associated with clinicopathological parameters such as invasion, lymph node metastasis, TNM stage, prognosis etc.. TUG1 regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. Mechanistically, TUG1 can bind to SP1 and PRC2. Moreover, TUG1 negatively regulates E-cadherin, miR-144, Bcl-2, KLF2 and positively regulates N-cadhe...


UBC1

alias symbols:

tissues bladder,stomach

cancer type bladder cancer,gastric cancer

LncRNA UBC1 is significantly up-regulated in gastric cancer tissues and bladder cancer. Furthermore, high UBC1 expression is associated with clinicopathological parameter such as lymph-node metastasis, tumor size, TNM stage and poorer prognosis. Functionally, UBC1 promotes proliferation, motility and invasion of gastric cancer cells. Moreover, UBC1 acts in trans and binds to PRC2 complex and suppresses its target genes in bladder cancer cell.


UCA1

alias symbols:

tissues bladder,bone,bone marrow,breast,colorectum,esophagus,kidney,liver,lung,others,ovary,prostate,stomach

cancer type acute myelocytic leukemia,bladder cancer,breast cancer,colorectal cancer,esophageal squamous cell cancer,gastric cancer,hepatic cancer,melanoma,non-small-cell lung cancer,osteosarcoma,ovarian cancer,prostate cancer,renal cancer,tongue squamous cell cancer

LncRNA UCA1 is higher in lung cancer, breast cancer, gastric cancer, hepatocellular carcinoma, colorectal cancer, melanoma, osteosarcoma, ovarian cancer, bladder cancer, renal cell carcinoma, while has dual roles in esophageal squamous cell carcinoma. UCA1 expression level is associated with clinicopathological parameters such as differentiation, tumor size, invasion depth, TNM stage, prognosis etc.. UCA1 regulates cancer cell proliferation, migration, metastasis, invasion, apoptosis and EMT. Mechanistically, UCA1 can bind to Ets-2, C/EBPα,BRG1(24993775),hnRNPI and miRNAs. Moreover, UCA1 re...


UNMIBC

alias symbols:

tissues bladder

cancer type bladder cancer

LncRNA UNMIBC is up-regulated in the primary non-muscle invasive bladder cancer and significantly associated with recurrence. Moreover, UNMIBC has a key role in G0/G1 arrest. Furthermore, RNA and chromatin immune-precipitation assays demonstrate that UNMIBC is physically associated with EZH2 and SUZ12, leading to an altered histone H3 lysine 27 methylation status of target genes.


ZEB2NAT

alias symbols:

tissues bladder

cancer type bladder cancer

LncRNA ZEB2NAT is demonstrated to be essential for TGFβ1-dependent process. ZEB2NAT depletion reverses CAF-CM-induced EMT and invasion of cancer cells, as well as reduces the ZEB2 protein level. Consistently, TGFβ1 mRNA expression is positively correlated with ZEB2NAT transcript and ZEB2 protein level in human bladder cancer specimens.


n336928

alias symbols:

tissues bladder

cancer type bladder cancer

LncRNA n336928 is significantly higher in bladder cancer tissues compared to that in adjacent noncancerous tissues, and correlated with bladder tumor stage, histological grade and overall survival time. Moreover, n336928 can be an independent prognostic factor for overall survival for bladder cancer patients.


ncRAN

alias symbols:

tissues bladder,colorectum

cancer type bladder cancer,colorectal cancer

LncRNA ncRAN is higher in bladder cancer and lower in colorectal cancer. It can regulate cancer cell proliferation, migration, and invasion.